Zai Lab treats first patient in China in PANOVA-3 trial of TTFields

By on    Pharma Industry News  

Zai Lab treats first patient in China in PANOVA-3 trial of TTFields

Zai Lab Limited said that it has treated the first patient in Greater China in the PANOVA-3 phase 3 clinical trial of tumor treating fields (TTFields) in pancreatic cancer. Tumor Treating Fields are electric fields which disrupt cancer cell division. PANOVA-3 is a global, open-label, randomized late-stage trial for assessing the efficacy of Tumor Treating […]

Five Prime Therapeutics and Zai Lab start Phase 3 study of bemarituzumab for advanced gastric cancer

By on    Pharma Industry News  

Five Prime Therapeutics and Zai Lab start Phase 3 study of bemarituzumab for advanced gastric cancer

California-based Five Prime Therapeutics and Chinese biopharma Zai Lab have initiated a pivotal Phase 3 trial of bemarituzumab (FPA144) in combination with chemotherapy for patients with advanced gastric cancer (GC) or gastroesophageal junction (GEJ) cancer. The trial, named FIGHT, represents a significant milestone in the development of targeted therapies for these challenging cancers. The FIGHT […]